Baltimore-based Johns Hopkins University has signed a deal with AstraZeneca's research and development arm MedImmune to collaborate on research projects in cancer; respiratory conditions, inflammation and autoimmunity; infectious disease; antibody development and protein engineering.
MedImmune confirms $6.5 million research deal with Johns Hopkins
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||